Biotech Stock News (RXII)(REGN)(SNY)(ESPR)(ISIS)(BIIB)
Rxi Pharmaceuticals (NASDAQ:RXII) On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects: First the new patent is … Read more